Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since assuming his current position and the organization’s business expansion strategy, based on enhancing patient access to innovative medicines in both the public and private sectors.
Mr. Paleja, you were appointed as country president and general manager of Novartis Pharmaceuticals in Indonesia back in March 2016. What was your assigned mission?
"We are committed to leveraging Novartis innovation and improving Indonesian patients’ lives."
